ArticlePloS one2025
Awareness, knowledge, and beliefs about Human Papillomavirus and its vaccine among Egyptian medical students: A cross-sectional national study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Real-world safety data of human papillomavirus vaccines after marketing in Shandong, China, August 2017-October 2025.Human vaccines & immunotherapeutics · 2026Article
- Epidemiology of Human Papillomavirus in the Middle East and North Africa: A Review of Genotypic Prevalence, Vaccination Challenges, and Non-Cervical Clinical Outcomes.Diseases (Basel, Switzerland) · 2026Review
- Association of the HPV vaccination intention‒behavior gap with ehealth literacy and health beliefs among chinese female college students: cross-sectional study.Scientific reports · 2026Article
- HPV Vaccination Knowledge and Awareness Among Male University Students in Malaysia: A Cross-Sectional Study.Vaccines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman papillomavirus (HPV) is a major cause of preventable cancers, including cervical, penile, and oropharyngeal cancers. Despite the availability of safe and effective vaccines, gaps in awareness, knowledge, and uptake persist globally, particularly in low- and middle-income countries. Medical students, as future healthcare providers, play a critical role in HPV prevention advocacy, making it important to understand their level of preparedness.
methodsA cross-sectional analytical study was conducted during the 2024-2025 academic year among medical students enrolled in faculties of medicine across Egypt. Eligible participants included undergraduate and internship-year students who voluntarily completed an online questionnaire adapted from the validated Karki et al. instrument, assessing HPV awareness, knowledge, beliefs, and vaccine uptake. The tool was reviewed by a panel of public health experts and pilot-tested among 30 students. Data were analyzed using descriptive statistics, chi-square tests, Mann-Whitney U tests, and multivariable logistic regression.
resultsA total of 1,431 students participated; 91.0% were aware of HPV. Awareness was significantly associated with older age (p = 0.003), Egyptian nationality (p < 0.001), higher academic year (p < 0.001), urban residence (p = 0.002), and prior HPV-related education (p < 0.001). Knowledge of sexual transmission was high (97-98%), yet misconceptions persisted-67% believed HPV typically causes symptoms (p < 0.001), and 50% incorrectly identified HPV as herpesvirus (p = 0.004). Vaccine-related knowledge was limited: 78% believed the vaccine causes serious adverse effects (p < 0.001), and 70-76% thought it was intended only for sexually active individuals (p = 0.03). Logistic regression confirmed academic seniority (AOR = 2.41, 95% CI 1.85-3.12), urban residence (AOR = 1.74, 95% CI 1.28-2.36), and prior HPV education (AOR = 3.06, 95% CI 2.14-4.38) as strong independent predictors of awareness. Gender differences were also observed: males were more willing to vaccinate (44% vs. 36%, p = 0.02) but perceived lower personal risk (8% vs. 12%, p = 0.04), whereas females expressed greater safety concerns (22% vs. 15%, p = 0.03), higher perceived stigma (p = 0.01), and stronger recognition of HPV's cancer threat (95% vs. 97%, p = 0.04).
conclusionWhile HPV awareness among Egyptian medical students is high, significant misconceptions about pathogenesis, prevention, and vaccine safety remain. Educational interventions, particularly those targeting early academic years, are essential to address these gaps, improve vaccine acceptance, and strengthen the role of future physicians in HPV prevention efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.